Delivery Order SPE2DR25D1100-SPE2DR26FCU7L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units with a ceiling value of $1,656.66. This firm fixed-price delivery order, which must be completed by July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,102.80. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 13, 2025, for the supply of Sevoflurane Inhalation Liquid in 250 milliliter quantities. The contract is a firm fixed-price delivery order valued at $2,403.92, with an ultimate completion date of November 14, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $4,563.40 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units. This contract employs firm fixed pricing and represents a non-set-aside competitive award, with an ultimate completion date of December 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $3,009.44. This was a firm fixed price contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The award represents a non-set-aside, competitively awarded procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,885.44 and a firm fixed price structure. The delivery order, which represents a non-competitive set-aside award, is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities under a firm fixed-price contract. The award, issued on November 24, 2025, carries a ceiling value of $2,630.16 with an ultimate completion date of November 25, 2025. This delivery order represents a non-set-aside, competitively awarded transaction and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Sevoflurane...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,519.52. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by December 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU7LDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,750.38 for Sevoflurane Inhalation Liquid in 250ml quantities under a firm fixed-price contract. This award, issued on December 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award, consistent with AmerisourceBergen's typical contract awards from the federal government. Sevoflurane is a volatile anesthetic commonly used in surgical and medical procedures within military and federal healthcare systems. This delivery order supports the DLA's mission to provide critical pharmaceutical and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. AmerisourceBergen's role as a prime vendor under the SPE2DX contract enables the company to fulfill diverse medical supply needs across multiple therapeutic domains, with the completion date scheduled for December 16, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/14/25 |